Pro-Assurance Corp (PRA) 51.35 $PRA ProAssurance's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pro-Assurance Corp (PRA) 51.35 $PRA

ProAssurance's Growth Prospects Dull Amid High Expenses
Zacks Equity Research - Zacks Investment Research - Fri May 27, 9:08AM CDT
On May 27, 2016, we issued an updated research report on ProAssurance Corporation (PRA).
CINF: 69.84 (-0.63), PRA: 51.35 (-0.70), NMIH: 5.69 (-0.18), MKL: 926.53 (-10.45)

ProAssurance Announces Results from 2016 Annual Meeting of Shareholders
PR Newswire - Wed May 25, 3:31PM CDT
Shareholders of ProAssurance Corporation (NYSE: PRA), acting at today's Annual Meeting of Shareholders, overwhelmingly elected Bruce D. Angiolillo to our Board, and also overwhelmingly re-elected John J. McMahon, Jr. and W. Stancil Starnes to our Board. Each received at least 95% of the votes cast by shareholders and will serve a three-year term ending at the Annual Meeting of Shareholders in 2019 and until their successors are elected and qualified.
PRA: 51.35 (-0.70)

ProAssurance Declares Quarterly Dividend
PR Newswire - Wed May 25, 3:30PM CDT
The Board of Directors of ProAssurance Corporation (NYSE: PRA) has declared a cash dividend of $0.31 per common share, payable on July 8, 2016 to shareholders who own our stock as of June 24, 2016.
PRA: 51.35 (-0.70)

Infinity Property and Casualty Corporation Holds Annual Meeting of Shareholders
PR Newswire - Tue May 17, 4:15PM CDT
Infinity Property and Casualty Corporation (NASDAQ: IPCC) today announced that the shareholders elected the nine director nominees to the Board of Directors at today's Annual Shareholders' Meeting. Other actions taken at the Annual Meeting included the approval by the shareholders of the proposals to ratify the appointment of Ernst & Young LLP as Infinity's independent registered public accounting firm, and to approve, on an advisory basis, the compensation of Infinity's named executive officers.
PRA: 51.35 (-0.70), IPCC: 78.61 (-1.05)

ProAssurance (PRA) Q1 Earnings, Revenues Meet Estimates
Zacks Equity Research - Zacks Investment Research - Tue May 10, 9:00AM CDT
ProAssurance Corporation (PRA) reported first-quarter 2016 operating earnings per share of 46 cents, in line with the Zacks Consensus Estimate.
PGR: 32.42 (-0.24), RLI: 65.81 (-1.31), PRA: 51.35 (-0.70), FAF: 37.53 (+0.09)

ProAssurance Reports Results for First Quarter 2016
PR Newswire - Mon May 09, 5:45AM CDT
ProAssurance Corporation (NYSE: PRA) reports the following results for First Quarter of 2016:
PRA: 51.35 (-0.70)

ProAssurance Announces Preliminary Results for First Quarter 2016
PR Newswire - Thu Apr 28, 3:30PM CDT
ProAssurance Corporation (NYSE: PRA) announced today that, despite strong underlying fundamentals in its insurance operations, we expect to report net income of between $0.35 and $0.37 per diluted share and operating earnings of between $0.45 and $0.47 per diluted share when we release final first quarter results on May 9, 2016. We anticipate net earned premium in the quarter of approximately $177 million and a consolidated combined ratio of approximately 94.5%.
PRA: 51.35 (-0.70)

ProAssurance Corporation Announces Date for First Quarter Earnings Release and Conference Call
PR Newswire - Mon Apr 11, 7:00AM CDT
ProAssurance Corporation (NYSE: PRA) will report results for the first quarter of 2016 prior to the opening of normal New York Stock Exchange trading on Monday, May 9, 2016.
PRA: 51.35 (-0.70)

ProAssurance Corporation Announces Dates for Fourth Quarter Earnings Release and Conference Call
PR Newswire - Mon Jan 25, 3:30PM CST
ProAssurance Corporation (NYSE: PRA) will report results for the fourth quarter of 2015 after the close of normal New York Stock Exchange trading on Tuesday, February 23, 2016.
PRA: 51.35 (-0.70)

Upgrade Alert for ProAssurance (PRA)
Comtex SmarTrend(R) - Thu Jan 21, 8:08AM CST
ProAssurance (NYSERA) was upgraded from Neutral to Buy at SunTrust today. The stock closed yesterday at $46.22 on volume of 252,000 shares, below average daily volume of 272,000. ProAssurance has overhead space with shares priced $46.22, or 11.8% below the average consensus analyst price target of $52.40. The stock should find initial resistance at its 200-day moving average (MA) of $48.46 and further resistance at its 50-day MA of $50.37.
PRA: 51.35 (-0.70)

ProAssurance's Capital Actions Look Good, Costs a Drag
Zacks Equity Research - Zacks Investment Research - Thu Dec 10, 10:50AM CST
We issued an updated research report on ProAssurance Corporation (PRA) on Dec 10, 2015.
CINF: 69.84 (-0.63), HALL: 10.45 (-0.04), PRA: 51.35 (-0.70), HRTG: 12.46 (-0.39)

ProAssurance Shares More Profit, OK's Special Dividend
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 3:35PM CST
In order to increase shareholder worth, the board of directors of ProAssurance Corporation (PRA) has declared a special dividend of $1.00 per share.
UIHC: 17.25 (-0.34), RLI: 65.81 (-1.31), PRA: 51.35 (-0.70), IPCC: 78.61 (-1.05)

ProAssurance declares special and regular quarterly dividends
M2 - Thu Dec 03, 5:27AM CST
The board of directors of ProAssurance Corporation (NYSERA) approved a special and regular common stock dividend of USD1.00 and USD0.31 per share, the company disclosed on Wednesday.
PRA: 51.35 (-0.70)

ProAssurance Announces Special Dividend
PR Newswire - Wed Dec 02, 3:18PM CST
The ProAssurance Corporation (NYSE: PRA) Board of Directors has authorized a special dividend of $1.00 per common share and a regular quarterly dividend of $0.31 per common share. Both dividends will be paid on January 8, 2016 to shareholders who own our stock as of December 24, 2015.
PRA: 51.35 (-0.70)

Fitch Affirms ProAssurance's Ratings; Outlook Stable
BusinessWire - Fri Nov 13, 2:41PM CST
Fitch Ratings has affirmed ProAssurance Corporation's (PRA) Issuer Default Rating (IDR) at 'A-'. Fitch has also affirmed the Insurer Financial Strength (IFS) ratings of PRA's primary insurance operating companies (listed below) at 'A'. The Rating Outlook for all ratings is Stable.
PRA: 51.35 (-0.70)

ProAssurance's (PRA) Q3 Earnings in Line, Revenues Miss
Zacks Equity Research - Zacks Investment Research - Thu Nov 05, 11:50AM CST
ProAssurance Corporation (PRA) reported third-quarter 2015 operating earnings per share of 63 cents, in line with the Zacks Consensus Estimate.
RLI: 65.81 (-1.31), PRE: 140.52 (+0.04), PRA: 51.36 (-0.69), ALL: 67.10 (-0.36)

ProAssurance Reports Results for Third Quarter 2015
PR Newswire - Wed Nov 04, 3:16PM CST
ProAssurance Corporation (NYSE: PRA) reports the following results for Third Quarter of 2015:
PRA: 51.36 (-0.69)

A. M. Best Takes Rating Action on ProAssurance Subsidiaries
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 10:20AM CDT
Recently, the issuer credit ratings of the subsidiaries of ProAssurance Corporation (PRA) were upgraded to "a+" from "a" by credit rating giant, A. M. Best Company.
HALL: 10.45 (-0.04), PRA: 51.36 (-0.69), CB: 124.93 (-0.87), TRV: 113.13 (-0.68)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 17

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 15

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 19

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 16

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 13

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 9

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 11

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 17

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Guaranty Bancshares Sale Investigation by Top Legal Team

Updated Category News Views 145

Understanding the Sale of Guaranty Bancshares, Inc. The recent announcement regarding the proposed sale of Guaranty Bancshares, Inc. to Glacier Bancorp, Inc. has garnered significant attention. Shareholders will reportedly receive 1.0000 share of Glacier stock for each share they hold in Guaranty. This transaction raises important questions regarding its valuation and the...

Continue Reading
Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas

Updated Category News Views 147

Ascenz Marorka Enhances Fleet Performance Monitoring in the Americas Ascenz Marorka, the smart shipping arm of GTT, has recently made strides by expanding its Real-Time Fleet Performance Monitoring Service to encompass the Americas. This strategic development follows the success of deployments in renowned maritime hubs, showcasing Ascenz Marorka's commitment to enhancing...

Continue Reading
Ares Management Expands Renewable Energy Footprint with New Acquisition

Updated Category News Views 334

Ares Management Expands Renewable Energy Footprint Recently, Ares Management Corporation (NYSE: ARES) announced a remarkable acquisition that underscores their commitment to renewable energy. A fund managed under the Ares Infrastructure Opportunities strategy has secured a 49% stake in a diverse energy asset portfolio valued at approximately $2.9 billion. This strategic...

Continue Reading
RLX Technology Set to Share Financial Insights This Quarter

Updated Category News Views 145

RLX Technology to Announce Third Quarter Financial Results Internationally recognized for its innovative approach, RLX Technology Inc. (NYSE: RLX) is gearing up to unveil its financial performance for the third quarter, which will end September 30, 2025. This announcement will occur just before the U.S. markets open on November 14, 2025. As a global leader in the e-vapor...

Continue Reading
Grok AI Gets Federal Approval: Key Insights for Musk and Trump

Updated Category News Views 302

Grok AI Federal Approval Marks a New Era The approval for Elon Musk's AI chatbot, Grok, to be utilized by all federal agencies represents a groundbreaking development in how artificial intelligence can enhance government operations. The General Services Administration (GSA) has granted this approval along with special provisions from Musk's AI company, xAI. Understanding...

Continue Reading